- $53.39m
- $7.36m
- $37.25m
- 60
- 42
- 59
- 54
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.18 | ||
| Price to Tang. Book | 1.2 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.3 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -173.37% | ||
| Return on Equity | -2457.08% | ||
| Operating Margin | -219.98% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 23.16 | 32.79 | 69.15 | 66.52 | 37.25 | 38.83 | 37 | 41.27% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Eargo, Inc. is a medical device company. The Company is engaged in developing products to improve the quality of life of people with hearing loss. Its Eargo hearing aids are virtually invisible, rechargeable, completely in-the-canal devices indicated to compensate for mild to moderate hearing loss. Its in-the-canal devices feature quality audio, which are designed to provide up to 16 hours of battery life and feature its soft flexible medical-grade silicon tips. It is marketing various versions of hearing aids, the Eargo Max, the Eargo Neo HiFi, Eargo 5, Eargo 6 and Eargo 7. The Company markets and sells its hearing aids primarily in a direct-to-consumer format, engaging consumers through a mix of digital and traditional marketing as well as select commercial partnership, and omni-channel (including retail). Its devices are self-fitting hearing aids and are adjusted by the user to meet the user’s hearing needs, without pre-programming or a hearing test from a hearing care professional.
Directors
- Joshua Makower NEC (57)
- Christian Gormsen PRE (44)
- Adam Laponis CFO (44)
- William Brownie COO (54)
- Mark Thorpe CAO (54)
- Juliet Bakker IND (59)
- Peter Bisgaard IND (47)
- Doug Hughes IND (59)
- Nina Richardson IND (62)
- A. Brooke Seawell IND (73)
- David Wu IND (52)
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- November 12th, 2010
- Public Since
- October 16th, 2020
- No. of Shareholders
- 67
- No. of Employees
- 243
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Global Select Market- Shares in Issue
- 20,772,485
- Address
- 2665 North First Street, Suite 300, SAN JOSE, 95134
- Web
- https://eargo.com/
- Phone
- +1 6503517700
- Auditors
- Deloitte & Touche LLP
Upcoming Events for EAR
Q1 2024 Eargo Inc Earnings Release
Eargo Inc Annual Shareholders Meeting
Q2 2024 Eargo Inc Earnings Release
Similar to EAR
10X Genomics
NASDAQ Global Select Market
Accuray
NASDAQ Global Select Market
Akoya Biosciences
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Alphatec Holdings
NASDAQ Global Select Market
FAQ
What is the Eargo share price?
As of Today at 18:07 UTC, shares in Eargo are trading at $2.57. This share price information is delayed by 15 minutes.
How has the Eargo share price performed this year?
Shares in Eargo last closed at $2.57 and the price had moved by -69.87% over the past 365 days. In terms of relative price strength the Eargo share price has underperformed the S&P500 Index by -75.45% over the past year.
What are the analyst and broker recommendations for Eargo?
The overall consensus recommendation for Eargo is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Eargo dividend yield?
Eargo does not currently pay a dividend.
Does Eargo pay a dividend?
Eargo does not currently pay a dividend.
When does Eargo next pay dividends?
Eargo does not currently pay a dividend.
How do I buy Eargo shares?
To buy shares in Eargo you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Eargo?
As of the previous close price of $2.57, shares in Eargo had a market capitalisation of $53.39m.
Where are Eargo shares listed?
Here are the trading details for Eargo:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: EAR
What kind of share is Eargo?
Based on an overall assessment of its quality, value and momentum Eargo is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Eargo share price forecast for 2024?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Eargo share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Eargo. Over the past six months, its share price has underperformed the S&P500 Index by -25.45%.
As of the last closing price of $2.57, shares in Eargo were trading -21.6% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Eargo PE Ratio?
The Eargo PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.57.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Eargo?
Eargo's management team is headed by:
- Joshua Makower - NEC
- Christian Gormsen - PRE
- Adam Laponis - CFO
- William Brownie - COO
- Mark Thorpe - CAO
- Juliet Bakker - IND
- Peter Bisgaard - IND
- Doug Hughes - IND
- Nina Richardson - IND
- A. Brooke Seawell - IND
- David Wu - IND